Moleculin Biotech, Inc. Interest Payable, Current
Moleculin Biotech, Inc. (MBRX) had Interest Payable, Current of $30.00 thousand as of 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2018-03-28
- 2017-06-30: Interest Payable, Current $30.00K.
- 2017-03-31: Interest Payable, Current $30.00K.
- 2016-12-31: Interest Payable, Current $7.17K.
- 2016-09-30: Interest Payable, Current $6.74K.
| Period end | Interest Payable, Current |
|---|---|
| 2017-06-30 | $30.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $30.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $7.17K 10-K · filed 2018-03-28 |
| 2016-09-30 | $6.74K 10-Q · filed 2016-11-21 |
| 2016-05-31 | $17.70K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |